Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Nutr Biochem ; 25(12): 1282-95, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25287815

RESUMO

The present study was elaborated to comparatively evaluate the preventive effect of different peach-derived products obtained from preserved fruits (Syrup and Preserve Pulp Peach [PPP]) and from fresh peels and pulps (Peel and Fresh Pulp Peach [FPP]) in a model of liver/renal toxicity and inflammation induced by carbon tetrachloride (CCl4) in rats. Tissue damage (carbonyl, thiobarbituric acid reactive species and sulfhydril), antioxidant enzymes activity (catalase and superoxide dismutase) and inflammatory parameters [tumor necrosis factor (TNF)-α and interleukin (IL)-1ß levels, and receptor for advanced glycation end-products (RAGE) and nuclear factor (NF)κB-p65 immunocontent] were investigated. Our findings demonstrated that Peel, PPP and FPP (200 or 400 mg/kg) daily administration by oral gavage for 30 days conferred a significant protection against CCl4-induced antioxidant enzymes activation and, most importantly, oxidative damage to lipids and proteins as well as blocked induction of inflammatory mediators such as TNF-α, IL-1ß, RAGE and NFκB. This antioxidant/anti-inflammatory effect seems to be associated with the abundance of carotenoids and polyphenols present in peach-derived products, which are enriched in fresh-fruit-derived preparations (Peel and FPP) but are also present in PPP. The Syrup - which was the least enriched in antioxidants - displayed no protective effect in our experiments. These effects cumulated in decreased levels of transaminases and lactate dehydrogenase leakage into serum and maintenance of organ architecture. Therefore, the herein presented results show evidence that supplementation with peach products may be protective against organ damage caused by oxidative stress, being interesting candidates for production of antioxidant-enriched functional foods.


Assuntos
Tetracloreto de Carbono/efeitos adversos , Frutas/química , Estresse Oxidativo/efeitos dos fármacos , Preparações de Plantas/farmacologia , Prunus/química , Alanina Transaminase/sangue , Animais , Antioxidantes/farmacologia , Aspartato Aminotransferases/sangue , Bilirrubina/sangue , Glicemia/metabolismo , Carotenoides/análise , Suplementos Nutricionais , Inflamação/induzido quimicamente , Inflamação/tratamento farmacológico , Interleucina-1beta/sangue , Rim/efeitos dos fármacos , Rim/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , NF-kappa B/sangue , Fitoterapia/métodos , Polifenóis/análise , Ratos , Ratos Wistar , Receptor para Produtos Finais de Glicação Avançada , Receptores Imunológicos/sangue , Superóxido Dismutase/sangue , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Fator de Necrose Tumoral alfa/sangue
2.
Phytother Res ; 28(11): 1615-24, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24840232

RESUMO

Advanced glycation end-products (AGEs) are considered potent molecules capable of promoting neuronal cell death and participating in the development of neurodegenerative disorders such as Alzheimer's disease (AD). Previous studies have shown that AGEs exacerbate ß-amyloid (Aß) aggregation and AGE-related cross-links are also detected in senile plaques. Acrolein (ACR) is an α, ß-unsaturated aldehyde found in the environment and thermally processed foods, which can additionally be generated through endogenous metabolism. The role of ACR in AD is widely accepted in the literature. Guarana (Paullinia cupana Mart.) is popularly consumed by the population in Brazil, mainly for its stimulant activity. In the present study, we showed that guarana (10, 100, and 1000 µg/mL) is able to prevent protein glycation, ß-amyloid aggregation, in vitro methylglyoxal, glyoxal, and ACR (20 µM)-induced toxicity on neuronal-like cells (SH-SY5Y). Since these are considered typical AD pathological hallmarks, we propose that guarana may deserve further research as a potential therapeutic agent in such a neurodegenerative disease.


Assuntos
Acroleína/efeitos adversos , Peptídeos beta-Amiloides/química , Produtos Finais de Glicação Avançada/metabolismo , Neurônios/efeitos dos fármacos , Paullinia/química , Fragmentos de Peptídeos/química , Extratos Vegetais/farmacologia , Agregação Patológica de Proteínas/prevenção & controle , Antioxidantes/farmacologia , Brasil , Linhagem Celular Tumoral , Humanos , Neuroblastoma , Espécies Reativas de Oxigênio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...